CONTE, PIETRO
 Distribuzione geografica
Continente #
NA - Nord America 202
AS - Asia 75
EU - Europa 63
SA - Sud America 12
AF - Africa 1
OC - Oceania 1
Totale 354
Nazione #
US - Stati Uniti d'America 197
SG - Singapore 31
FI - Finlandia 21
IT - Italia 16
CN - Cina 14
VN - Vietnam 12
BR - Brasile 9
HK - Hong Kong 8
UA - Ucraina 6
DE - Germania 5
GB - Regno Unito 5
MX - Messico 3
BG - Bulgaria 2
CA - Canada 2
FR - Francia 2
IE - Irlanda 2
KR - Corea 2
PL - Polonia 2
TR - Turchia 2
VE - Venezuela 2
AR - Argentina 1
AU - Australia 1
CI - Costa d'Avorio 1
IL - Israele 1
IN - India 1
IQ - Iraq 1
JP - Giappone 1
PH - Filippine 1
RU - Federazione Russa 1
SE - Svezia 1
TW - Taiwan 1
Totale 354
Città #
Ashburn 22
Fairfield 22
Singapore 22
Helsinki 19
Seattle 19
Woodbridge 19
Houston 12
Cambridge 11
Council Bluffs 10
Wilmington 10
San Jose 9
Hong Kong 8
Jacksonville 8
Trieste 6
Ann Arbor 5
Chandler 5
Ho Chi Minh City 5
Beijing 4
Boardman 4
Princeton 4
Buffalo 3
Columbus 3
São Paulo 3
Beauharnois 2
Chicago 2
Dublin 2
Falls Church 2
Hanoi 2
Heidelberg 2
Lauterbourg 2
Lavis 2
Long Xuyen 2
Nanjing 2
Norwalk 2
Nuremberg 2
Pignone 2
Shenzhen 2
Sofia 2
Zgierz 2
Abidjan 1
Altinópolis 1
Ankara 1
Brejo 1
Caracas 1
Cuiabá 1
Culiacán 1
Da Nang 1
Dallas 1
Des Moines 1
Diadema 1
Fortaleza 1
Funabashi 1
Hobart 1
Izmir 1
London 1
Los Angeles 1
Manchester 1
Manila 1
Miguel Hidalgo 1
Milan 1
Monterrey 1
Moscow 1
New York 1
Orem 1
Ramos Mejía 1
Redwood City 1
Rio de Janeiro 1
Rome 1
San Cristóbal 1
San Diego 1
Santa Clara 1
Simi Valley 1
Surat 1
Taipei 1
Tel Aviv 1
Turin 1
Wembley 1
Totale 303
Nome #
Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: Primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET) 203
Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-Positive breast cancer patients treated with chemotherapy and HER2-Targeted agents in the CherLOB trial 159
Totale 362
Categoria #
all - tutte 1.144
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.144


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 4 0 4
2021/202223 0 2 0 0 1 4 2 1 5 3 2 3
2022/202318 2 0 1 1 4 4 0 3 0 0 2 1
2023/202415 0 3 0 0 0 2 0 5 0 2 1 2
2024/202535 0 2 2 2 2 9 0 8 2 2 4 2
2025/2026122 4 1 4 2 8 10 29 4 30 30 0 0
Totale 362